Cite
HARVARD Citation
Brown, M. et al. (2020). Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study. Open forum infectious diseases. p. . [Online].